C24H2oCl2Cu2N4Na204, triclinic, PI (No. 2), a = 8.366(2) Ä, b = 8.832(3) Ä, c = 9.410(3) Ä, α = 101.75(2)°, β = 100.83(2)°, γ = 105.18(2)°, V = 635.2 Χ 3 , Z= 1, RgdF) = 0.065, wRteffF 2 ) = 0.148, T= 293 K.
Source of materialUnder continuous stirring, 0.43 g (2.52 mmol) copper dichloride dihydrate (CuCh · 2H2O), 0.5 g (2.52 mmol) 1,10-phenanthroline monohydrate (C12H8N2 · H2O) and 0.33 g (2.52 mmol) glutaric acid (HOOC(CH2)3COOH) were successively added to 50 ml CH3OH/H2O (1:1 v/v), leading to a greenish slurry. After being filtered, the residual greenish slurry in the filter was then washed with a concentrated Na2CC>3 solution and a blue filtrate was collected. A small amount of blue crystals were grown by slow evaporation at room temperature for several weeks.
DiscussionThe crystal structure of the title compound consists of Na + cations, hydrogen bonded OH -anions and dinuclear [CU2CI2 (phen)2(OH)2] complex molecules centered at the crystallographic Id positions. The Cu atoms are penta-coordinated by one bidentate chelating phenanthroline ligand, two bridging hydroxide groups and one CI atom to form a distorted square pyramid with two phen Ν atoms ant two hydroxide Ο atoms at the basal positions and the CI atom at the apical position (
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.